{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-221242","form_type":"8-K","ticker":"ABOS","cik":"0001576885","company_name":"Acumen Pharmaceuticals, Inc.","filed_at":"2022-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.227507+00:00","generated_at":"2026-06-23T23:50:50.750358+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Acumen Q2 net loss $10.2M; cash $209.9M; Phase 1 topline H1 2023; director resigns","bullets":["Cash, cash equivalents and marketable securities $209.9M as of June 30, 2022; expected runway through 2025.","Net loss $10.2M for Q2 2022 vs $61.4M in Q2 2021 (2021 incl $57.9M non-cash liability charge).","R&D expenses $7.3M (up from $2.3M) due to ongoing Phase 1 INTERCEPT-AD trial.","Phase 1 INTERCEPT-AD topline results expected H1 2023; 15 active sites recruiting.","Dr. Jeffrey Sevigny resigned from Board effective Aug 12, 2022 due to employment requirements, not disagreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-221242","json":"https://secwatch.observer/filing/0001193125-22-221242.json","markdown":"https://secwatch.observer/filing/0001193125-22-221242.md","text":"https://secwatch.observer/filing/0001193125-22-221242.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1576885/000119312522221242/0001193125-22-221242-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1576885/000119312522221242/d254943d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T23:50:50.750358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"69bf6201a8","claim":"Jeffrey Sevigny resigned as Director at Acumen Pharmaceuticals, Inc..","evidence_excerpt":"On August 12, 2022, Dr. Jeffrey Sevigny notified the Board of Directors of his resignation from the Board of Directors, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1576885/000119312522221242/0001193125-22-221242-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}